leadf
logo-loader
viewCardiol Therapeutics

Cardiol Therapeutics signs supply agreement with Medical Cannabis by Shoppers

.

Cardiol Therapeutics ((TSX: CRDL; OTCQX: CRTPF) CEO David Elsley joined Steve Darling from Proactive to discuss the company announcing a supply agreement with Medical Cannabis by Shoppers. 

Elsley discusses what this deal means for the company having a name like Shoppers associated with them, and also what is the potential market size.

Quick facts: Cardiol Therapeutics

Price: 3.05 CAD

TSX:CRDL
Market: TSX
Market Cap: $99.99 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cardiol Therapeutics named herein, including the promotion by the Company of Cardiol Therapeutics in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Cardiol Therapeutics receives FDA approval for Phase 2/3 COVID-19 trial with...

Cardiol Therapeutics Inc. (TSE: CRDL-OTCQX: CRTPF) President and CEO David Elsley joined Steve Darling from Proactive with news the company has been given the go-ahead for an investigational new drug application to commence a Phase II/III, double-blind, a placebo-controlled clinical trial...

5 days, 7 hours ago

2 min read